eTheRNA immunotherapies
Phase 2etherna pioneers in mRNA-LNP platforms, offering custom drug delivery platforms for tailored and innovative LNP drug delivery solutions
Founded
2013
Focus
ImmunologyRNA TherapeuticsVaccines
About
etherna pioneers in mRNA-LNP platforms, offering custom drug delivery platforms for tailored and innovative LNP drug delivery solutions
Funding History
2Total raised: $73M
Series B$39MNovalis BiotechJun 15, 2022
Series A$34MPMVJan 15, 2020
Company Info
TypePrivate
Founded2013
LocationNiel, Belgium
StagePhase 2
Contact
SIMILAR COMPANIES
Miracor Medical
Pre-clinical · Zaventem
AML Clinical Services
Pre-clinical · Leuven
Anacura
Pre-clinical · Ghent
Aseptic Technologies
Pre-clinical · Gembloux
Aspect Analytics
Pre-clinical · Leuven
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile